Anika Therapeutics reported $36.69M in Sales Revenues for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbott ABT:US $ 11895M 427M
Acorda Therapeutics ACOR:US $ 22.53M 14.43M
Agenus AGEN:US $ 25.94M 5.68M
Anika Therapeutics ANIK:US $ 36.69M 0.87M
Arrowhead Research ARWR:US $ 151.8M 124.37M
Chemocentryx CCXI:US $ 5.46M 3.14M
Clovis Oncology CLVS:US $ 34.25M 1.72M
Enanta Pharmaceuticals ENTA:US $ 18.72M 8.93M
Halozyme Therapeutics HALO:US $ 117.28M 15.28M
Heron Therapeutics HRTX:US $ 23.46M 2.8M
Immunogen IMGN:US $ 38.08M 10.09M
Insmed INSM:US $ 53.11M 3.02M
Integra Lifesciences IART:US $ 376.64M 28.89M
Intrexon XON:US $ 32.02M 7.8M
Karyopharm Therapeutics KPTI:US $ 47.67M 78.6M
Ligand Pharmaceuticals LGND:US $ 45.69M 26.78M
Merit Medical Systems MMSI:US $ 275.41M 3.08M
Peregrine Pharmaceuticals PPHM:US $ 31.51M 5.4M
Rigel Pharmaceuticals RIGL:US $ 16.74M 3.67M
Sangamo Biosciences SGMO:US $ 28.23M 0.24M
Stryker SYK:US $ 4275M 426M
Surmodics SRDX:US $ 26.11M 3.1M
Veracyte VCYT:US $ 67.78M 0.45M
Xencor XNCR:US $ 85.5M 68.52M
Zimmer Biomet Holdings Inc ZBH:US $ 1.66B 374.7M